Palleiko Benjamin L — SEC insider filings

SEC reporting owner CIK 1366244. 50 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers all 50 filings on record, filed 2020-12-18 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
KalVista Pharmaceuticals, Inc. (KALV)CHIEF EXECUTIVE OFFICER, Director49—40 legs · 363,633 sh · $5,632,168126
Frazier Life Sciences Acquisition Corp. II (FLSC)Director1———

Insider filings — Palleiko Benjamin L

FiledFormIssuerReported transactionsSource
2026-10-133Frazier Life Sciences Acquisition Corp. II (FLSC)Holdings only — no transactions reportedEDGAR
2026-06-114KalVista Pharmaceuticals, Inc. (KALV)Disposition to issuer (D): 479,989 @ $0 · Disposition to issuer (D): 47,354 (derivative) · Disposition to issuer (D): 29,611 (derivative) · Disposition to issuer (D): 33,800 (derivative) · Disposition to issuer (D): 71,700 (derivative) · Disposition to issuer (D): 52,600 (derivative) · +12 moreEDGAR
2026-05-264KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 23,250 · Sale (S): 10,926 @ $26.78 · Option exercise (M): 23,250 (derivative) @ $0EDGAR
2026-05-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 2,419 · Sale (S): 1,129 @ $26.76 · Option exercise (M): 2,419 (derivative) @ $0EDGAR
2026-05-134KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 7,120 · Sale (S): 3,322 @ $26.71 · Option exercise (M): 7,120 (derivative) @ $0EDGAR
2026-04-204KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 20,312 · Sale (S): 9,550 @ $20.22 · Option exercise (M): 20,312 (derivative) @ $0EDGAR
2026-03-104KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 6,693 @ $16.08 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2026-02-244KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 23,250 · Sale (S): 10,034 @ $15.57 · Option exercise (M): 23,250 (derivative) @ $0EDGAR
2026-02-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 2,419 · Sale (S): 1,038 @ $15 · Option exercise (M): 2,419 (derivative) @ $0EDGAR
2026-02-134KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 7,120 · Sale (S): 3,354 @ $15.70 · Option exercise (M): 7,120 (derivative) @ $0EDGAR
2026-01-214KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 325,000 (derivative) @ $0EDGAR
2025-12-094KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 7,294 @ $16.51 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2025-11-264KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 23,250 · Sale (S): 10,940 @ $13.45 · Option exercise (M): 23,250 (derivative) @ $0EDGAR
2025-11-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 9,364 · Sale (S): 4,466 @ $14.48 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0EDGAR
2025-11-134KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 7,120 · Sale (S): 3,328 @ $11.55 · Option exercise (M): 7,120 (derivative) @ $0EDGAR
2025-09-094KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 7,294 @ $15.84 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2025-08-254KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 23,250 · Sale (S): 10,940 @ $13.22 · Option exercise (M): 23,250 (derivative) @ $0EDGAR
2025-08-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 9,362 · Sale (S): 4,409 @ $13.19 · Option exercise (M): 2,418 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0EDGAR
2025-08-134KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 113,920 (derivative) @ $0 · Grant/award (A): 113,920 (derivative) @ $0EDGAR
2025-07-104KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 87,500 · Sale (S): 32,979 @ $15.69EDGAR
2025-06-104KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 7,169 @ $14.50 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2025-05-234KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 23,250 · Sale (S): 9,999 @ $11.88 · Option exercise (M): 23,250 (derivative) @ $0EDGAR
2025-05-204KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 9,364 · Sale (S): 3,808 @ $11.84 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0EDGAR
2025-03-104KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 6,669 @ $11.97 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2025-02-254KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 372,000 (derivative) @ $0EDGAR
2025-02-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 9,363 · Sale (S): 5,104 @ $9.82 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0EDGAR
2024-12-094KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 7,627 @ $9.75 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2024-11-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 30,198 · Sale (S): 14,400 @ $9.26 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0 · Option exercise (M): 20,834 (derivative) @ $0EDGAR
2024-09-104KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 7,352 @ $12.19 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2024-08-214KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 30,195 · Sale (S): 14,215 @ $12.01 · Option exercise (M): 2,418 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0EDGAR
2024-06-104KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 15,625 · Sale (S): 7,465 @ $11.53 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2024-05-214KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 51,031 · Sale (S): 21,959 @ $11.76 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0 · Option exercise (M): 20,834 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0EDGAR
2024-03-084KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 250,000 (derivative) @ $0EDGAR
2024-02-214KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 51,029 · Sale (S): 22,802 @ $14.11 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 6,944 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0EDGAR
2024-02-164KalVista Pharmaceuticals, Inc. (KALV)Sale (S): 40,855 @ $15.01EDGAR
2024-02-134KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 87,500 · Grant/award (A): 83,333 (derivative) @ $0EDGAR
2023-11-214KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 30,197 · Sale (S): 13,008 @ $8.23 · Option exercise (M): 6,945 (derivative) @ $0 · Option exercise (M): 2,419 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0EDGAR
2023-08-214KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 30,195 · Sale (S): 13,067 @ $10.73 · Option exercise (M): 6,944 (derivative) @ $0 · Option exercise (M): 2,418 (derivative) @ $0 · Option exercise (M): 20,833 (derivative) @ $0EDGAR
2023-05-224/AKalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 6,944 (derivative) @ $0EDGAR
2023-05-224KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-05-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 9,364 · Sale (S): 4,037 @ $10.14 · Grant/award (A): 83,334 (derivative) @ $0 · Option exercise (M): 6,945 (derivative) @ $0 · Option exercise (M): 2,419 (derivative) @ $0EDGAR
2023-02-234KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 9,363 · Sale (S): 4,954 @ $7.66 · Option exercise (M): 6,944 (derivative) @ $0 · Option exercise (M): 2,419 (derivative) @ $0EDGAR
2022-11-214KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 2,419 · Sale (S): 722 @ $5.44 · Option exercise (M): 2,419 (derivative) @ $0EDGAR
2022-08-194KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 2,418 · Sale (S): 725 @ $14.96 · Option exercise (M): 2,418 (derivative) @ $0EDGAR
2022-05-194KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 25,800 (derivative) @ $0 · Grant/award (A): 38,700 (derivative) @ $0EDGAR
2021-05-284KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2021-02-254KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 29,642 @ $6.74 · Sale (S): 1,000 @ $35.40 · Sale (S): 22,093 @ $33.73 · Sale (S): 5,293 @ $33.06 · Sale (S): 1,256 @ $31.77 · Option exercise (M): 29,642 (derivative) @ $0EDGAR
2021-02-084KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 32,500 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-01-044KalVista Pharmaceuticals, Inc. (KALV)Option exercise (M): 358 @ $6.74 · Sale (S): 358 @ $20.04 · Option exercise (M): 358 (derivative) @ $0EDGAR
2020-12-184KalVista Pharmaceuticals, Inc. (KALV)Grant/award (A): 85,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1366244 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs